NCT06068348

Liquid Biopsy Collection Study

Collection of Human Blood for Development of Liquid Biopsy Assay

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 60 (estimated)
• Sponsor: University of Central Florida · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to develop a liquid biopsy approach for detection of circulating tumor cells (CTC) that could be used in place of the more invasive and potentially risky methods of tissue biopsy. The aims of the project are: (a) determine whether the Chaperonin-Containing TCP-1 (CCT) chaperonin can used to identify rare cancer cells in blood, and (b) establish whether the cancer cells detected using the CCT chaperonin for identification have invasive or metastatic potential.

Conditions

• Chaperonin-Containing TCP-1
• Circulating Tumor Cells
• CCT
• CTC

Timeline

• Start date: 2021-10-07
• Primary completion: 2023-10-31
• Completion: 2025-10-01
• First posted: 2023-10-05
• Last updated: 2024-12-06

Locations

1 site across 1 country: United States